In Re: National Prescription Opiate Litigation

Track this case

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. July 20, 2020

    Opioid Judge 'Concerned' About Amerisource Hiding Docs

    An Ohio federal judge on Monday ordered AmerisourceBergen Drug Corp. to reevaluate why it hasn't produced key documents in opioid multidistrict litigation, saying Monday that he is "concerned" by new omissions and frequent changes in privilege designations. 

  2. July 17, 2020

    Product Liability Cases To Watch In 2020: Midyear Review

    Among upcoming product liability cases in the rest of 2020 are oral arguments this fall before the U.S. Supreme Court involving jurisdiction questions in automaker Ford's challenges to a pair of defect suits, as well as an expected rise in suits related to COVID-19 claims. Here are Law360's cases to watch for the rest of the year.

  3. July 16, 2020

    6th Circ. Again Refuses To Boot Judge From Opioid MDL

    The Sixth Circuit on Thursday shot down a second bid to disqualify an Ohio federal judge from overseeing the opioid multidistrict litigation after CVS Pharmacy Inc. and other national pharmacy chains accused him of blatant bias.

  4. July 13, 2020

    'Unfounded Attacks' On Opioid Judge Must Fail, 6th Circ. Told

    CVS Pharmacy Inc., Walgreen Co. and other national pharmacy chains are making phony bias allegations against the Ohio federal judge overseeing multidistrict opioid litigation because they're upset about having lost several legal arguments, local governments have told the Sixth Circuit.

  5. July 07, 2020

    Bias Charge Is 'Dangerous Fiction,' Opioid MDL Judge Says

    The Ohio federal judge overseeing multidistrict opioid litigation lambasted Walgreen Co., CVS Health Corp. and other pharmacy giants Tuesday for seeking his disqualification from the sprawling MDL, telling the Sixth Circuit that allegations of bias are reckless and untrue.

  6. July 07, 2020

    Amerisource Tries To Save CEO From Opioid Bellwether Depo

    AmerisourceBergen Drug Corp. has urged a West Virginia federal judge to undo a special master's order that its CEO testify in the second bellwether opioid suit expected to head to trial in federal multidistrict litigation, arguing that the ruling opens the floodgates to "limitless" depositions of the executive.

  7. July 06, 2020

    Pharmacies Can't Slip Opioid Nuisance Claims, Counties Say

    Two Ohio counties urged a federal judge to shut down requests by pharmacy chains to toss claims that they created a public nuisance by failing to monitor suspicious opioid orders that helped fuel an epidemic of painkiller addiction, saying the state's public nuisance law fits their claims.

  8. June 30, 2020

    Pharmacies Urge 6th Circ. To Boot Opioid MDL Judge

    CVS Health Corp., Walgreen Co. and other major pharmacy chains asked the Sixth Circuit on Tuesday to disqualify the Ohio federal judge supervising multidistrict opioid litigation, accusing him of exhibiting blatant bias by "directing plaintiffs' trial strategy."

  9. June 29, 2020

    AmerisourceBergen CEO Must Testify In Opioid Bellwether

    Virginia Special Master Christopher C. Wilkes on Monday ordered AmerisourceBergen Drug Corp. CEO Steven H. Collis to testify in the second bellwether opioid suit expected to head to trial in federal multidistrict litigation, rejecting the company's arguments taking his video-deposition would be too burdensome.

  10. June 23, 2020

    Chicago Says Drug Cos. Shouldn't Exit Opioid Bellwether Suit

    Johnson & Johnson and Teva Pharmaceuticals can't escape a Chicago bellwether case over their allegedly deceptive opioid marketing because earlier rulings have already largely upheld the allegations, the city argued Monday.